Folic acid for the prevention of neural tube defects

American Family Physician

Volumn 82, Issue 12, 2010, Pages 1533-1534

  Lin, Kenneth W ^a   Birmingham, Eileen ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; FOLIC ACID; VITAMIN B COMPLEX;

BRAIN PROTECTION; DOSE RESPONSE; DRUG USE; FAMILY HISTORY; HUMAN; MATERNAL DIABETES MELLITUS; NEURAL TUBE DEFECT; NOTE; OBESITY; RECOMMENDED DRUG DOSE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VITAMIN SUPPLEMENTATION; ADULT; ARTICLE; CASE REPORT; FEMALE; METHODOLOGY; PREGNANCY; PRENATAL CARE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL CARE; VITAMIN B COMPLEX;

EID: 79952276549     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Note

References (2)

1. U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(9):626-631.
2. Wolff T, Witkop CT, Miller T, Syed SB. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;150(9):632-639